Reports Q2 revenue $2.76B, consensus $2.73B. “Through continued execution of our strategy, we delivered a strong second quarter, with revenues growing 15.2% which includes 5.2% from organic revenues, as well as adjusted EPS growth of 11.5%,” said Jim Davis, chairman, CEO and president.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DGX:
- Notable companies reporting before tomorrow’s open
- Quest Diagnostics price target lowered to $175 from $176 at UBS
- Quest Diagnostics introduces testing for Oropouche virus
- Quest Diagnostics: Strategic Positioning and Growth Potential Amid Reimbursement Challenges
- Quest Diagnostics to develop multi-cancer blood test with MD Anderson Center